» Articles » PMID: 37096191

Trends and Socioeconomic, Demographic, and Environmental Factors Associated with Antimicrobial Resistance: a Longitudinal Analysis in 39 Hospitals in Chile 2008-2017

Overview
Date 2023 Apr 25
PMID 37096191
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Antimicrobial resistance (AMR) is among the most critical global health threats of the 21st century. AMR is primarily driven by the use and misuse of antibiotics but can be affected by socioeconomic and environmental factors. Reliable and comparable estimates of AMR over time are essential to making public health decisions, defining research priorities, and evaluating interventions. However, estimates for developing regions are scant. We describe the evolution of AMR for critical priority antibiotic-bacterium pairs in Chile and examine their association with hospital and community-level characteristics using multivariate rate-adjusted regressions.

Methods: Drawing on multiple data sources, we assembled a longitudinal national dataset to analyse AMR levels for critical priority antibiotic-bacterium combinations in 39 private and public hospitals (2008-2017) throughout the country and characterize the population at the municipality level. We first described trends of AMR in Chile. Second, we used multivariate regressions to examine the association of AMR with hospital characteristics and community-level socioeconomic, demographic, and environmental factors. Last, we estimated the expected distribution of AMR by region in Chile.

Findings: Our results show that AMR for priority antibiotic-bacterium pairs steadily increased between 2008 and 2017 in Chile, driven primarily by resistant to third-generation cephalosporins and carbapenems, and vancomycin-resistant . Higher hospital complexity, a proxy for antibiotic use, and poorer local community infrastructure were significantly associated with greater AMR.

Interpretation: Consistent with research in other countries in the region, our results show a worrisome increase in clinically relevant AMR in Chile and suggest that hospital complexity and living conditions in the community may affect the emergence and spread of AMR. Our results highlight the importance of understanding AMR in hospitals and their interaction with the community and the environment to curtail this ongoing public health crisis.

Funding: This research was supported by the Agencia Nacional de Investigación y Desarrollo (ANID), Fondo Nacional de Desarrollo Científico y Tecnológico FONDECYT, The Canadian Institute for Advanced Research (CIFAR), and Centro UC de Políticas Públicas, Pontificia Universidad Católica de Chile.

Citing Articles

Cost-effectiveness of screening, decolonisation and isolation strategies for carbapenem-resistant Enterobacterales and methicillin-resistant infections in hospitals: a sex-stratified mathematical modelling study.

Allel K, Garcia P, Peters A, Munita J, Undurraga E, Yakob L Lancet Reg Health Am. 2025; 43:101019.

PMID: 40027374 PMC: 11872075. DOI: 10.1016/j.lana.2025.101019.


Impact of inappropriate empirical antibiotic therapy on in-hospital mortality: a retrospective multicentre cohort study of patients with bloodstream infections in Chile, 2018-2022.

Allel K, Peters A, Furuya-Kanamori L, Spencer-Sandino M, Pitchforth E, Yakob L BMJ Public Health. 2025; 2(2):e001289.

PMID: 40018577 PMC: 11816519. DOI: 10.1136/bmjph-2024-001289.


Unveiling the drivers of vancomycin-resistant enterococcus in China: A comprehensive ecological study.

Wang J, Li X, Du X, Jia H, Chen H, Wu J Infect Med (Beijing). 2025; 4(1):100159.

PMID: 39911600 PMC: 11794159. DOI: 10.1016/j.imj.2024.100159.


Longitudinal monitoring of sewershed resistomes in socioeconomically diverse urban neighborhoods.

Lee J, Xiang K, Au E, Sarabi S, Acosta N, Bhatnagar S Commun Med (Lond). 2025; 5(1):7.

PMID: 39775111 PMC: 11707339. DOI: 10.1038/s43856-024-00729-y.


Excess burden of antibiotic-resistant bloodstream infections: evidence from a multicentre retrospective cohort study in Chile, 2018-2022.

Allel K, Peters A, Haghparast-Bidgoli H, Spencer-Sandino M, Conejeros J, Garcia P Lancet Reg Health Am. 2024; 40:100943.

PMID: 39605961 PMC: 11600772. DOI: 10.1016/j.lana.2024.100943.


References
1.
Smith R, Coast J . The true cost of antimicrobial resistance. BMJ. 2013; 346:f1493. DOI: 10.1136/bmj.f1493. View

2.
Chatterjee A, Modarai M, Naylor N, Boyd S, Atun R, Barlow J . Quantifying drivers of antibiotic resistance in humans: a systematic review. Lancet Infect Dis. 2018; 18(12):e368-e378. DOI: 10.1016/S1473-3099(18)30296-2. View

3.
Roope L, Smith R, Pouwels K, Buchanan J, Abel L, Eibich P . The challenge of antimicrobial resistance: What economics can contribute. Science. 2019; 364(6435). DOI: 10.1126/science.aau4679. View

4.
Hay S, Rao P, Dolecek C, Day N, Stergachis A, Lopez A . Measuring and mapping the global burden of antimicrobial resistance. BMC Med. 2018; 16(1):78. PMC: 5985573. DOI: 10.1186/s12916-018-1073-z. View

5.
Okeke I, Lamikanra A, Edelman R . Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis. 1999; 5(1):18-27. PMC: 2627681. DOI: 10.3201/eid0501.990103. View